Damora Therapeutics grants options for 144,400 shares to new hires at $21.28 exercise price

• Damora Therapeutics granted inducement stock options covering 144,400 ordinary shares to five newly hired non-executive employees.
• Options carry a 10-year term with an exercise price of $21.28 per share.
• Vesting starts with 25% on the first anniversary of each employee’s start date, then monthly installments over 36 months.
• Awards were issued on Oct. 1, 2026 under the 2022 Inducement Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020759PRIMZONEFULLFEED9838670) on October 02, 2026, and is solely responsible for the information contained therein.